drugset / Trial / NCT02944214
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether febuxostat and benzbromarone could protect renal function in chinese, and which one could be better.
Timeline
- Start
- 2016-10
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benzbromarone | Small molecule | 12.5 mg | Oral |
| Subject | Benzbromarone | Small molecule | 100 mg | Oral |
| Subject | Febuxostat | Small molecule | 10 mg | Oral |
| Subject | Febuxostat | Small molecule | 80 mg | Oral |